C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 17/08 (2006.01) A61K 31/7048 (2006.01) A61K 31/7052 (2006.01) A61P 1/04 (2006.01) A61P 31/04 (2006.01)
Patent
CA 2654450
The present disclosure is directed to novel macrolide antibiotics of Formula (I) and pharmaceutically acceptable salts and prodrugs thereof; and the chemical syntheses and medical uses of these novel macrolide antibiotics for the treatment and/or management of infections caused by various aerobic and anaerobic gram-positive and gram-negative microorganisms as well as various mycobacteria.
La présente invention concerne de nouveaux antibiotiques macrolides de formule (I) et des sels et promédicaments pharmaceutiquement acceptables de ceux-ci ; et la synthèse chimique et les utilisations médicales de ces nouveaux antibiotiques macrolides pour le traitement et/ou le contrôle d'infections causées par différents micro-organismes aérobies et non aérobies, Gram positif et Gram négatif ainsi que différentes mycobactéries.
Gant Thomas G.
Sarshar Sepehr
Auspex Pharmaceuticals Inc.
Mcfadden Fincham
LandOfFree
Preparation and utility of substituted erythromycin analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation and utility of substituted erythromycin analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation and utility of substituted erythromycin analogs will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1905475